Home | Contact Us 

Online Catalog

View our online catalog.
For further information or for a quotation, call 1-510-475-0650 or email us at

How Can We Help You?
Click here to contact us!


Sepragen Announces Senior Management Addition

Union City, CA, November 7, 2000 - Sepragen Corporation (OTC BB: SPGNA), a provider of patented technology and equipment for purification needs in the nutritional and biotech industries, today has announced the addition of Jim Spradling as acting President and COO. Jim has joined the company as a consultant in the capacity of acting President and COO and will formally become President and COO after completion of a proposed financing for the company.

Jim has a distinguished professional track record with over 32 years executive management experience at Raychem. Jim joined Raychem when it was under $10 million in revenues and left as Senior Vice President when the company had grown to over $1.6 billion. Jim had P & L responsibility for a $400 million sector. During his tenure at Raychem, Jim directed the corporate technical center and established and managed several international operations and joint ventures. No stranger to technology and entrepreneurial endeavors, Jim said, "I believe Sepragen has a tremendous technology portfolio, a dedicated team and significant growing market opportunities. I look forward to helping Sepragen transition to its commercialization phase."

Welcoming Jim, Vinit Saxena, Sepragen's Chairman, commented, "We are excited about Jim joining Sepragen. I believe that Jim can contribute the management depth and experience needed to help transition our vision into commercially vibrant opportunity. We are working on securing additional capital to undertake this transition."

Sepragen Corporation is a leading supplier of separation process technology, equipment and consumables to the biotechnology and nutraceutical industries. In addition to its biotech drug separation business, the company has developed patented applications that provide large market opportunities in the food and beverage industry, including debittering citrus juices, extracting isoflavone (plant estrogen) from soy, as well as extracting proteins from whey. The company holds over 14 issued patents relating to its core technology.

Return to News Archives main page

The statements in this release that relate to future events or performance, statements about growth, future regulatory clearances, levels of sales and market size and future manufacturing capacity and efficiencies are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to the development of markets for and commercial acceptance of the company's products and services, the availability of components, competitors' product introductions and other risks identified in the company's SEC filings. Actual results may differ from those described in these forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.

Company | Products | News and Events | Contact Us | Terms and Conditions | Privacy Policy © 2020 Sepragen Corporation. All rights reserved. (510) 475-0650